Code | 5097D | ||||||||||
MA number | 29/0159/20-S | ||||||||||
Product Form: | gel 1x180 g (tuba Al) | ||||||||||
MA Status: | R - Valid Marketing Authorisation | ||||||||||
Type of procedure: | Decentralised | ||||||||||
MAH, country: | Teva B.V., Netherland | ||||||||||
Therapeutic Class: | 29 - ANTIRHEUMATICA, ANTIPHLOGISTICA, ANTIURATICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 24 | ||||||||||
Container: | tube Al | ||||||||||
Route of admin.: | Cutaneous use |
Prescription Status: | Medicinal product not subject to medical prescription. |
Legal basis: | Article 10(3) hybrid application |
MA issued: | 16.07.2020 |
Validity: | 16.07.2025 |
MA renewed: | Renewal application submitted |
Pediatric indication: | Yes |
Pediatric posology: | Yes |
Pediatric contraindication: | Yes |
Pediatric warnings: | Yes |
SPC: | SPC_Olfen Forte 23,2 mg_g gél_07.2021.pdf |
PIL: | PIL_Olfen Forte 23,2 mg_g gél_07.2021.pdf |
Safety feature | No |
Data update: | 20.07.2020 |